8-K: Safety Shot Secures $1 Million Investment from President's Family Fund

Safety Shot, Inc. has received a $1 million private placement investment from Core 4 Capital Corp., a family investment group associated with the company's President, Jordan Schur.

Summary

• Safety Shot, Inc. entered into a Securities Purchase Agreement with Core 4 Capital Corp. on June 27, 2024, for a $1 million private placement.
• The company issued 943,396 shares at $1.06 per share, which was the closing price on June 27, 2024.
• Core 4 Capital Corp. is associated with Safety Shot's President, Jordan Schur, who owns 15% of the investment group.
• The net proceeds from the offering were approximately $1 million, with no commissions paid.
• This investment is in addition to a previous $5 million investment from Core 4 Capital Corp. in April 2024.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to the successful capital raise, the lack of commissions, and the continued support from the company's President. The investment is seen as a positive step for the company's growth and development.

Positives

• The company secured $1 million in funding with minimal expenses.
• The investment demonstrates confidence from the company's President in Safety Shot's potential.
• The private placement was completed at the market closing price with no discount.
• The company avoided paying commissions, maximizing the net proceeds from the offering.
• The investment is in addition to a previous $5 million investment, showing continued support from the investor.

Risks

• The company's President has a significant ownership stake in the investor, which could present a conflict of interest.
• The document mentions potential dilution of existing shares due to the issuance of new shares.
• The company is subject to various regulations, including those of the FDA, which could impact its operations.

Future Outlook

The company plans to use the proceeds for general corporate purposes, including working capital and potential acquisitions. They are also introducing business-to-business sales of Safety Shot throughout 2024.

Management Comments

• Jordan Schur stated he has seen promise in the company from the very beginning and is excited about the progress over the last four months.
• Schur believes Safety Shot's growth trajectory is a testament to the innovation of their product and the demand for this type of solution in the market.
• Schur stated he can't see a better use of his family's funds than to help the continued advancement of the Company in these early stages.

Industry Context

The investment reflects a continued interest in the wellness and dietary supplement market, particularly for products like Safety Shot that address specific needs such as lowering blood alcohol content. The company is expanding its sales channels to include business-to-business sales, which is a common strategy for growth in this sector.

Comparison to Industry Standards

• The private placement was completed at the market closing price, which is a standard practice for such transactions.
• The company's avoidance of commissions is a positive sign, as many offerings result in less than 90% of proceeds going to the company.
• The company's focus on business-to-business sales is a common strategy for growth in the wellness and dietary supplement industry, similar to companies like Nutrabolt and Herbalife.
• The company's product, Safety Shot, is a patented wellness product, which is a unique selling point compared to other dietary supplements.

Related Party Transactions

• The private placement involved Core 4 Capital Corp., an investment group associated with Safety Shot's President, Jordan Schur, who owns 15% of the investor.

Stakeholder Impact

• Shareholders may experience dilution due to the issuance of new shares.
• Employees may benefit from the company's increased financial stability and growth prospects.
• Customers may see increased availability of Safety Shot through expanded sales channels.
• Suppliers may benefit from increased orders as the company grows.
• Creditors may view the company as a lower risk due to the additional capital.

Next Steps

• The company will use the proceeds for general corporate purposes, including working capital and potential acquisitions.
• Safety Shot will continue to introduce business-to-business sales of its product throughout 2024.
• The company will maintain the listing of its common stock on the Nasdaq Capital Market.

Key Dates

Keywords

private placement, equity financing, securities purchase agreement, capital raise, Jordan Schur, Core 4 Capital Corp, Safety Shot, share issuance